Navigation Links
China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
Date:8/23/2011

1, Nepstar had a total of 2,511 stores in operation.

Revenue for the quarter increased by 7.3% to RMB606.6 million (US$93.8 million), compared to revenue of RMB565.2 million for the same period in 2010. Increase in sales of non-pharmaceutical products continued to reduce the negative impact on drug sales from ongoing healthcare reform that has led to price cuts and the diversion of patients from drugstores.

Second quarter revenue contribution from prescription drugs was 19.1%, OTC drugs was 35.2%, nutritional supplements was 19.1%, traditional Chinese herbal products was 3.8% and convenience and other products was 22.8%.

Same store sales (for 2,239 stores opened before December 31, 2009) for the second quarter of 2011 increased by 9.8% compared to the same period in 2010. This growth was mainly attributable to increased sales of non-pharmaceutical products.  

Nepstar's portfolio of private label products included 1,818 products as of June 30, 2011. Sales of private label products represented approximately 31.3% of revenue and 42.3% of gross profit for the second quarter of 2011. The Company continued to make efforts to provide high-quality yet reasonably-priced private label products in the convenience products category. In the second quarter, private label products' contribution to sales of the convenience products category reached 27.2%, helping maintain a reasonably favorable gross profit margin level on sales of convenience products.

Second quarter gross profit was RMB289.9 million (US$44.9 million), compared to RMB283.2 million in the same period of 2010. Gross margin in the second quarter of 2011 was 47.8%, compared to 50.1% in the second quarter of 2010 and 47.7% in the first quarter of 2011. The decrease in gross margin year over year was mainly due to mandatory price cuts on pharmaceuticals and changes in revenue mix as the Company introduced more convenience products with a lower gross margin.

Sales, marke
'/>"/>

SOURCE China Nepstar Chain Drugstore Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  Celsion Corporation (NASDAQ: ... Company will host a conference call to discuss ... on its development programs for ThermoDox®, its proprietary ... acquired technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy ... Thursday, March 12, 2015. To participate in the ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "India Pharma Outlook 2015: Accelerating ... value chain beyond Generics" report to their offering. ... from the slump in the 2013 caused by the ... 2015, growth is expected to continue to be healthy, ...
(Date:3/5/2015)... , March 5, 2015 Mallinckrodt ... global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held ... into a definitive agreement under which a subsidiary of ... Dearborn -led investor group in a transaction valued at ... closing conditions, the parties expect the transaction to be ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release ... Tuesday, August 17, 2010 , after the markets close. Cardica,s management will host a conference ... update on the company,s business. , , , ... , , , ...
... 4 PolyGel® is proud to announce that their ThermoActive ™ Cold & Hot ... , , ... , , ... , This is ...
Cached Medicine Technology:Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010 2PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis 2
(Date:3/5/2015)... March 05, 2015 For PASCHA Chocolate, ... most essential ingredients, the robust flavor of the cacao ... PASCHA Chocolate is free from peanuts, nuts, dairy, ... PASCHA's offering March 6th- 8th at Expo West., ... PASCHA Chocolate has broken new ground with their New ...
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted compensation ... its 2015 Children’s Hospitals Executive Compensation Survey. This ... and the survey results are exclusive to participants. ... on 60 executive and director level positions, and ... subsidiary children’s hospitals. Additionally, it provided a separate ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... and Arnold Fitness EXPO in Columbus, Ohio ... a display booth featuring free samples of its superior ... class-leading fat burner Synedrex. The company will also be ... its top-of-the-line supplements and miniature action figures of its ...
(Date:3/5/2015)... March 05, 2015 Nutrition Leaders, a ... is pleased to offer reformulated Millennium 500 Creatine to ... 500 is a German grade creatine supplement that has ... muscle recovery, and aid with overall strength gains in ... acts as a reserve energy source in the body ...
(Date:3/5/2015)... Utah (PRWEB) March 05, 2015 Jordan ... by LifeVest® as a treatment option for sudden cardiac ... monitors heart rhythm and can detect any life-threatening abnormalities. ... will alert the patient before delivering a treatment shock ... Dr. Adam Elhaddi of Jordan Valley Medical Center and ...
Breaking Medicine News(10 mins):Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
... highlights need for complete, unbiased information on Medicare choices. ... ... 2008 - Medicare beneficiaries trying to sort through their healthcare ... them against overly aggressive marketing tactics by some insurance companies ...
... the resulting acne scars which last long after ... distress. Now, a new study recently published ... issue), the peer-reviewed professional journal of the American ... a novel laser device combining CO2 ablation with ...
... States to End the Tobacco Settlement Spending Spree and Direct ... WASHINGTON, Nov. 19 This Sunday, November 23, ... of the largest civil settlement in United States history. The ... 46 states and the major tobacco companies that reimbursed the ...
... Project Report Makes Recommendations for System in Critical Need of ... 17 Weaknesses in food safety policy, organization and communications ... according to a report released today by the Produce Safety ... Georgetown University . , ...
... 18 Women who undergo weight-loss surgery, known as bariatric surgery, ... lower risk for pregnancy-related diabetes and high blood pressure -- ... -- than pregnant women who are obese, according to new ... are published in the November 19 issue of JAMA. ...
... Strange Appointed to CEO position and Will Join Board, Effective ... MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ -- Gentiva ... provider of comprehensive home health services, announced today that its ... Effective January 1, 2009, Tony Strange will become the Company,s ...
Cached Medicine News:Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 2Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 3Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 4Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 2Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 3Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 4Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 2Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 3Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 2Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4
Inquire...
... DNA and RNA fragments from 100 bp ... a standard melting temperature multi-purpose agarose that ... Its high gel strength specification ensures that ... during Southern and Northern transfers. UltraPure™ ...
... Agarose with low electroendosmosis ... most DNA/RNA applications. If ... to be used as ... ligase and restriction endonucleases, ...
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Medicine Products: